Supplementary Material for: Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study
Kerstin Folkerts(Bayer (Germany)), Csaba P. Kövesdy(University of Tennessee Health Science Center), Priscilla Velentgas(Aetion (United States)), Michael Blankenburg(Bayer (Germany)), Kelly A.M.B., Natalia Petruski‐Ivleva(AVEO Oncology (United States)), A. Gay, Linda F. Fried(VA Pittsburgh Healthcare System)
Cited by 0
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
|Nature Genetics|2018|1.5k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886